Skip to main content
NCBI home page
Bulletin of the World Health Organization logoLink to Bulletin of the World Health Organization
. 1988;66(4):499–506.

Chronic arsenic toxicity from drinking tubewell water in rural West Bengal

D N Guha Mazumder, A K Chakraborty, A Ghose, J D Gupta, D P Chakraborty, S B Dey, N Chattopadhyay
PMCID: PMC2491171  PMID: 3262450

Abstract

Hepatic damage caused by chronic exposure to arsenic has been frequently described. Here we report on 13 patients from West Bengal, India, who consumed large amounts of arsenic in drinking water. An epidemiological investigation of the study area showed evidence of chronic arsenical dermatosis and hepatomegaly in 62 (92.5%) of 67 members of families who drank contaminated water (arsenic level, 0.2-2 mg/l). In contrast, only six (6.25%) of 96 persons from the same area who drank safe water (arsenic level, <0.05 mg/l) had non-specific hepatomegaly, while none had skin lesions. Hepatomegaly occurred in all the 13 patients who were studied in detail, although five had splenomegaly. Biopsy of samples of liver from these patients revealed various degrees of fibrosis and expansion of the portal zone that resembled non-cirrhotic portal fibrosis (NCPF).

Full text

PDF
499

Images in this article

502Fig 3
on p.502
501Fig 1
on p.501
501Fig 2
on p.501

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Basu A. K., Boyer J., Bhattacharya R., Mallik K. C., Sen Gupta K. P. Non-cirrhotic portal fibrosis with portal hypertension: a new syndrome. I. Clinical and function studies and results of operations. Indian J Med Res. 1967 Apr;55(4):336–350. [PubMed] [Google Scholar]
  2. Chakraborty A. K., Saha K. C. Arsenical dermatosis from tubewell water in West Bengal. Indian J Med Res. 1987 Mar;85:326–334. [PubMed] [Google Scholar]
  3. Datta D. V. Letter: Arsenic and non-cirrhotic portal hypertension. Lancet. 1976 Feb 21;1(7956):433–433. doi: 10.1016/s0140-6736(76)90282-8. [DOI] [PubMed] [Google Scholar]
  4. Datta D. V., Mitra S. K., Chhuttani P. N., Chakravarti R. N. Chronic oral arsenic intoxication as a possible aetiological factor in idiopathic portal hypertension (non-cirrhotic portal fibrosis) in India. Gut. 1979 May;20(5):378–384. doi: 10.1136/gut.20.5.378. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. FRANKLIN M., BEAN W. B., HARDIN R. C. Fowler's solution as an etiologic agent in cirrhosis. Am J Med Sci. 1950 Jun;219(6):589–596. doi: 10.1097/00000441-195006000-00001. [DOI] [PubMed] [Google Scholar]
  6. Guha Mazumdar D. N., Ghose A., Pal N. C., Mukherjee J., Guharay B. N. Search for aetiological factors of non-cirrhotic portal fibrosis. Indian J Gastroenterol. 1984 Jan;3(1):25–26. [PubMed] [Google Scholar]
  7. Guharay B. N., Sain P., Banerjee D., Guha Majumdar D. N., Sengupta K. P., Basu A. K. Direct splenocaval shunt for selective decompression of portal hypertension in children. Surgery. 1980 Mar;87(3):271–279. [PubMed] [Google Scholar]
  8. Huet P. M., Guillaume E., Cote J., Légaré A., Lavoie P., Viallet A. Noncirrhotic presinusoidal portal hypertension associated with chronic arsenical intoxication. Gastroenterology. 1975 May;68(5 Pt 1):1270–1277. [PubMed] [Google Scholar]
  9. Nayak N. C., Ramalingaswami V. Obliterative portal venopathy of the liver. Associated with so-called idiopathic portal hypertension or tropical splenomegaly. Arch Pathol. 1969 Apr;87(4):359–369. [PubMed] [Google Scholar]
  10. Sama S. K., Bhargava S., Nath N. G., Talwar J. R., Nayak N. C., Tandon B. N., Wig K. L. Noncirrhotic portal fibrosis. Am J Med. 1971 Aug;51(2):160–169. doi: 10.1016/0002-9343(71)90234-8. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the World Health Organization are provided here courtesy of World Health Organization

RESOURCES